Purified human serum PON1 does not protect LDL against oxidation in the in vitro assays initiated with copper or AAPH (Q24302314)

negative regulation of plasma lipoprotein oxidation

GOA release 2020-03-11

1 reference

Journal of Lipid Research

GOA release 2020-03-11

copper

0 references

author name string

John F Teiber

series ordinal

1

0 references

Dragomir I Draganov

series ordinal

2

0 references

Bert N La Du

series ordinal

3

0 references

language of work or name

English

0 references

publication date

December 2004

0 references

published in

0 references

volume

45

0 references

page(s)

2260-8

0 references

issue

12

0 references

cites work

Pharmacogenetics of paraoxonases: a brief review

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Paraoxonase and coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

The oxidative modification hypothesis of atherogenesis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Paraoxonase and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Human serum paraoxonase 1 decreases macrophage cholesterol biosynthesis: possible role for its phospholipase-A2-like activity and lysophosphatidylcholine formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

The mechanism of action of antioxidants against lipoprotein peroxidation, evaluation based on kinetic experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Direct phasing at low resolution of a protein copurified with human paraoxonase (PON1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

LDL-associated phospholipase A does not protect LDL against lipid peroxidation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Kinetics of lipid peroxidation in mixtures of HDL and LDL, mutual effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

7 January 2021

Microsomal lipid peroxidation

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

7 January 2021

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

7 January 2021

Hydrolysis of platelet-activating factor by human serum paraoxonase

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

7 January 2021

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

7 January 2021

Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions: PON1 esterase and peroxidase-like activities

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400213-JLR200

7 January 2021